Contemporary Management of HIV: Emerging ART Paradigms

Join us for an engaging discussion with 2 experts who will lead a case-based discussion on emerging ART strategies, including rapid ART initiation, dual therapy, and long-acting antiretrovirals.


Program Overview
Case-based Discussion:

  • Rapid ART
  • Evolving Issues in Combination Therapy
  • Evolving Options for Switch Therapy
  • On-demand PrEP

Question and Answer Session


Date / Time
Event Details


Roger Bedimo, MD

Professor of Medicine
Division of Infectious Diseases
University of Texas Southwestern Medical Center
Section Chief
Division of Infectious Diseases
Department of Internal Medicine
VA North Texas Health Care System
Dallas, Texas

Ian Frank, MD

Professor of Medicine
University of Pennsylvania
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Philadelphia, Pennsylvania

David Hardy, MD

Adjunct Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland
Senior Director of Evidence-Based Practices
Whitman-Walker Health
Washington, DC

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Goal Statement
The goal of this activity is to improve participants’ competence in providing optimal care for HIV-infected patients through the appropriate use of contemporary antiretroviral regimens.

Target Audience
This program is intended for physicians, registered nurses, physician assistants, pharmacists, and other healthcare professionals who provide care for HIV-infected patients.

Learning Objectives 

  • Incorporate data on evolving first-line treatment paradigms into the individualized care of HIV-infected patients, as appropriate
  • Provide insightful counsel to patients and colleagues regarding emerging switch strategies for patients with HIV
  • Evaluate the impact of clinical studies of investigational antiretroviral therapies and strategies on future patient management



Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity or enduring material for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 2.5 contact hours.

Pharmacist Continuing Education

CCO designates this continuing education activity for 2.5 contact hours (0.25 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number JA4008176-0000-19-022-L02-P.

Type of Activity: Application

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.